{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:36Z","timestamp":1790484336423,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Environmental light has deleterious effects on the outer retina in human retinopathies, such as <jats:italic>ABCA4<\/jats:italic>-related Stargardt\u2019s disease and dry age-related macular degeneration. These effects involve carbonyl and oxidative stress, which contribute to retinal cell death and vision loss. Here, we used an albino <jats:italic>Abca4<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mouse model, the outer retina of which shows susceptibility to acute photodamage, to test the protective efficacy of a new polyunsaturated fatty acid lipophenol derivative. Anatomical and functional analyses demonstrated that a single intravenous injection of isopropyl-phloroglucinol-DHA, termed IP-DHA, dose-dependently decreased light-induced photoreceptor degeneration and preserved visual sensitivity. This protective effect persisted for 3 months. IP-DHA did not affect the kinetics of the visual cycle in vivo or the activity of the RPE65 isomerase in vitro. Moreover, IP-DHA administered by oral gavage showed significant protection of photoreceptors against acute light damage. In conclusion, short-term tests in <jats:italic>Abca4<\/jats:italic>-deficient mice, following single-dose administration and light exposure, identify IP-DHA as a therapeutic agent for the prevention of retinal degeneration.<\/jats:p>","DOI":"10.1038\/s12276-020-0460-7","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T05:33:44Z","timestamp":1594186424000},"page":"1090-1101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Preclinical pharmacology of a lipophenol in a mouse model of light-induced retinopathy"],"prefix":"10.1038","volume":"52","author":[{"given":"Nicolas","family":"Taveau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Cubizolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Guillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pinquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esp\u00e9rance","family":"Moine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Kalatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Vercauteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Crauste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2739-1622","authenticated-orcid":false,"given":"Philippe","family":"Brabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"460_CR1","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fphar.2018.01280","volume":"9","author":"I Bellezza","year":"2018","unstructured":"Bellezza, I. Oxidative stress in age-related macular degeneration: Nrf2 as therapeutic target. Front. Pharmacol. 9, 1280 (2018).","journal-title":"Front. Pharmacol."},{"key":"460_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.preteyeres.2011.11.001","volume":"31","author":"JJ Hunter","year":"2012","unstructured":"Hunter, J. J. et al. The susceptibility of the retina to photochemical damage from visible light. Prog. Retin. Eye Res. 31, 28\u201342 (2012).","journal-title":"Prog. Retin. Eye Res."},{"key":"460_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jphotobiol.2014.07.016","volume":"140","author":"Y Liu","year":"2014","unstructured":"Liu, Y., Zhang, D., Wu, Y. & Ji, B. Docosahexaenoic acid aggravates photooxidative damage in retinal pigment epithelial cells via lipid peroxidation. J. Photochem. Photobiol. B 140, 85\u201393 (2014).","journal-title":"J. Photochem. Photobiol. B"},{"key":"460_CR4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1011-1344(01)00227-5","volume":"64","author":"M Boulton","year":"2001","unstructured":"Boulton, M., Rozanowska, M. & Rozanowski, B. Retinal photodamage. J. Photochem. Photobiol. B 64, 144\u2013161 (2001).","journal-title":"J. Photochem. Photobiol. B"},{"key":"460_CR5","first-page":"450","volume":"5","author":"WK Noell","year":"1966","unstructured":"Noell, W. K., Walker, V. S., Kang, B. S. & Berman, S. Retinal damage by light in rats. Invest. Ophthalmol. 5, 450\u2013473 (1966).","journal-title":"Invest. Ophthalmol."},{"key":"460_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/75614","volume":"25","author":"C Grimm","year":"2000","unstructured":"Grimm, C. et al. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nat. Genet. 25, 63\u201366 (2000).","journal-title":"Nat. Genet."},{"key":"460_CR7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1751-1097.2011.00921.x","volume":"87","author":"D van Norren","year":"2011","unstructured":"van Norren, D. & Gorgels, T. G. The action spectrum of photochemical damage to the retina: a review of monochromatic threshold data. Photochem. Photobiol. 87, 747\u2013753 (2011).","journal-title":"Photochem. Photobiol."},{"key":"460_CR8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1562\/2004-11-13-IR-371","volume":"81","author":"M Rozanowska","year":"2005","unstructured":"Rozanowska, M. & Sarna, T. Light-induced damage to the retina: role of rhodopsin chromophore revisited. Photochem. Photobiol. 81, 1305\u20131330 (2005).","journal-title":"Photochem. Photobiol."},{"key":"460_CR9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1751-1097.2012.01161.x","volume":"88","author":"M Rozanowska","year":"2012","unstructured":"Rozanowska, M., Handzel, K., Boulton, M. E. & Rozanowski, B. Cytotoxicity of all-trans-retinal increases upon photodegradation. Photochem. Photobiol. 88, 1362\u20131372 (2012).","journal-title":"Photochem. Photobiol."},{"key":"460_CR10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.tibs.2010.01.005","volume":"35","author":"J von Lintig","year":"2010","unstructured":"von Lintig, J., Kiser, P. D., Golczak, M. & Palczewski, K. The biochemical and structural basis for trans-to-cis isomerization of retinoids in the chemistry of vision. Trends Biochem. Sci. 35, 400\u2013410 (2010).","journal-title":"Trends Biochem. Sci."},{"key":"460_CR11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1083\/jcb.200612010","volume":"177","author":"S Nickell","year":"2007","unstructured":"Nickell, S., Park, P. S., Baumeister, W. & Palczewski, K. Three-dimensional architecture of murine rod outer segments determined by cryoelectron tomography. J. Cell Biol. 177, 917\u2013925 (2007).","journal-title":"J. Cell Biol."},{"key":"460_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4419-5635-4_8","volume":"703","author":"Y Tsybovsky","year":"2010","unstructured":"Tsybovsky, Y., Molday, R. S. & Palczewski, K. The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease. Adv. Exp. Med. Biol. 703, 105\u2013125 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"460_CR13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.exer.2010.08.013","volume":"91","author":"RO Parker","year":"2010","unstructured":"Parker, R. O. & Crouch, R. K. Retinol dehydrogenases (RDHs) in the visual cycle. Exp. Eye Res. 91, 788\u2013792 (2010).","journal-title":"Exp. Eye Res."},{"key":"460_CR14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/bs.pmbts.2015.06.009","volume":"134","author":"CB Wright","year":"2015","unstructured":"Wright, C. B., Redmond, T. M. & Nickerson, J. M. A history of the classical visual cycle. Prog. Mol. Biol. Transl. Sci. 134, 433\u2013448 (2015).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"460_CR15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1751-1097.2012.01143.x","volume":"88","author":"T Maeda","year":"2012","unstructured":"Maeda, T., Golczak, M. & Maeda, A. Retinal photodamage mediated by all-trans-retinal. Photochem. Photobiol. 88, 1309\u20131319 (2012).","journal-title":"Photochem. Photobiol."},{"key":"460_CR16","doi-asserted-by":"crossref","first-page":"19273","DOI":"10.1073\/pnas.0708714104","volume":"104","author":"SR Kim","year":"2007","unstructured":"Kim, S. R. et al. The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model. Proc. Natl Acad. Sci. USA 104, 19273\u201319278 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"460_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1194\/jlr.R000687","volume":"51","author":"JR Sparrow","year":"2010","unstructured":"Sparrow, J. R., Wu, Y., Kim, C. Y. & Zhou, J. Phospholipid meets all-trans-retinal: the making of RPE bisretinoids. J. Lipid Res. 51, 247\u2013261 (2010).","journal-title":"J. Lipid Res."},{"key":"460_CR18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchembio.759","volume":"8","author":"A Maeda","year":"2011","unstructured":"Maeda, A. et al. Primary amines protect against retinal degeneration in mouse models of retinopathies. Nat. Chem. Biol. 8, 170\u2013178 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"460_CR19","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1172\/JCI80950","volume":"125","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Molecular pharmacodynamics of emixustat in protection against retinal degeneration. J. Clin. Invest. 125, 2781\u20132794 (2015).","journal-title":"J. Clin. Invest."},{"key":"460_CR20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/jpet.117.240721","volume":"362","author":"PD Kiser","year":"2017","unstructured":"Kiser, P. D. et al. Rational tuning of visual cycle modulator pharmacodynamics. J. Pharm. Exp. Ther. 362, 131\u2013145 (2017).","journal-title":"J. Pharm. Exp. Ther."},{"key":"460_CR21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.6.5.6","volume":"6","author":"AE Sears","year":"2017","unstructured":"Sears, A. E. et al. Towards treatment of stargardt disease: workshop organized and sponsored by the foundation fighting blindness. Transl. Vis. Sci. Technol. 6, 6 (2017).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"460_CR22","doi-asserted-by":"crossref","unstructured":"Crauste, C. et al. in European Journal of Organic Chemistry 4548\u20134561 (Wiley Online library, 2014).","DOI":"10.1002\/ejoc.201402282"},{"key":"460_CR23","doi-asserted-by":"publisher","unstructured":"Cubizolle, A. et al. Isopropyl-phloroglucinol-DHA protects outer retinal cells against lethal dose of all-trans-retinal. J Cell. Mol. Med. https:\/\/doi.org\/10.1111\/jcmm.15135 (2020).","DOI":"10.1111\/jcmm.15135"},{"key":"460_CR24","doi-asserted-by":"crossref","first-page":"340520","DOI":"10.1155\/2015\/340520","volume":"2015","author":"M Reinisalo","year":"2015","unstructured":"Reinisalo, M., Karlund, A., Koskela, A., Kaarniranta, K. & Karjalainen, R. O. Polyphenol stilbenes: molecular mechanisms of defence against oxidative stress and aging-related diseases. Oxid. Med. Cell Longev. 2015, 340520 (2015).","journal-title":"Oxid. Med. Cell Longev."},{"key":"460_CR25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jnutbio.2018.09.029","volume":"63","author":"G Drouin","year":"2019","unstructured":"Drouin, G. et al. Comparative effects of dietary n-3 docosapentaenoic acid (DPA), DHA and EPA on plasma lipid parameters, oxidative status and fatty acid tissue composition. J. Nutr. Biochem. 63, 186\u2013196 (2019).","journal-title":"J. Nutr. Biochem."},{"key":"460_CR26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.ASN.0000045047.44107.0B","volume":"14","author":"ML Kielar","year":"2003","unstructured":"Kielar, M. L., Jeyarajah, D. R., Zhou, X. J. & Lu, C. Y. Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. J. Am. Soc. Nephrol. 14, 389\u2013396 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"460_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/1480-9222-14-9","volume":"14","author":"LR Ferguson","year":"2012","unstructured":"Ferguson, L. R., Balaiya, S., Grover, S. & Chalam, K. V. Modified protocol for in vivo imaging of wild-type mouse retina with customized miniature spectral domain optical coherence tomography (SD-OCT) device. Biol. Proced. Online 14, 9 (2012).","journal-title":"Biol. Proced. Online"},{"key":"460_CR28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050231","volume":"7","author":"K Chekroud","year":"2012","unstructured":"Chekroud, K. et al. Fatp1 deficiency affects retinal light response and dark adaptation, and induces age-related alterations. PLoS ONE 7, e50231 (2012).","journal-title":"PLoS ONE"},{"key":"460_CR29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180148","volume":"12","author":"A Cubizolle","year":"2017","unstructured":"Cubizolle, A., Guillou, L., Mollereau, B., Hamel, C. P. & Brabet, P. Fatty acid transport protein 1 regulates retinoid metabolism and photoreceptor development in mouse retina. PLoS ONE 12, e0180148 (2017).","journal-title":"PLoS ONE"},{"key":"460_CR30","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1073\/pnas.1008769107","volume":"107","author":"G Moiseyev","year":"2010","unstructured":"Moiseyev, G. et al. Inhibition of the visual cycle by A2E through direct interaction with RPE65 and implications in Stargardt disease. Proc. Natl Acad. Sci. USA 107, 17551\u201317556 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"460_CR31","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1167\/iovs.14-13867","volume":"55","author":"L Wu","year":"2014","unstructured":"Wu, L., Ueda, K., Nagasaki, T. & Sparrow, J. R. Light damage in Abca4 and Rpe65rd12 mice. Invest. Ophthalmol. Vis. Sci. 55, 1910\u20131918 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"460_CR32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.exer.2017.02.007","volume":"155","author":"LT Adler","year":"2017","unstructured":"Adler, L. T., Chen, C. & Koutalos, Y. All-trans retinal levels and formation of lipofuscin precursors after bleaching in rod photoreceptors from wild type and Abca4(\u2212\/\u2212) mice. Exp. Eye Res. 155, 121\u2013127 (2017).","journal-title":"Exp. Eye Res."},{"key":"460_CR33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/978-1-4419-1399-9_61","volume":"664","author":"L Wu","year":"2010","unstructured":"Wu, L., Nagasaki, T. & Sparrow, J. R. Photoreceptor cell degeneration in Abcr (\u2212\/\u2212) mice. Adv. Exp. Med. Biol. 664, 533\u2013539 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"460_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124940","volume":"10","author":"C Bavik","year":"2015","unstructured":"Bavik, C. et al. Visual cycle modulation as an approach toward preservation of retinal integrity. PLoS ONE 10, e0124940 (2015).","journal-title":"PLoS ONE"},{"key":"460_CR35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125631","volume":"10","author":"S Volland","year":"2015","unstructured":"Volland, S., Esteve-Rudd, J., Hoo, J., Yee, C. & Williams, D. S. A comparison of some organizational characteristics of the mouse central retina and the human macula. PLoS ONE 10, e0125631 (2015).","journal-title":"PLoS ONE"},{"key":"460_CR36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajo.2013.05.003","volume":"156","author":"K Fujinami","year":"2013","unstructured":"Fujinami, K. et al. Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function. Am. J. Ophthalmol. 156, 487\u2013501 (2013). e481.","journal-title":"Am. J. Ophthalmol."},{"key":"460_CR37","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1167\/iovs.13-11688","volume":"54","author":"P Charbel Issa","year":"2013","unstructured":"Charbel Issa, P. et al. Fundus autofluorescence in the Abca4(\u2212\/\u2212) mouse model of Stargardt disease\u2013correlation with accumulation of A2E, retinal function, and histology. Invest. Ophthalmol. Vis. Sci. 54, 5602\u20135612 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"460_CR38","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1167\/iovs.15-18033","volume":"57","author":"C Dysli","year":"2016","unstructured":"Dysli, C., Wolf, S., Hatz, K. & Zinkernagel, M. S. Fluorescence lifetime imaging in stargardt disease: potential marker for disease progression. Invest. Ophthalmol. Vis. Sci. 57, 832\u2013841 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"460_CR39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ophtha.2017.11.020","volume":"125","author":"KN Khan","year":"2018","unstructured":"Khan, K. N. et al. Early patterns of macular degeneration in ABCA4-associated retinopathy. Ophthalmology 125, 735\u2013746 (2018).","journal-title":"Ophthalmology"},{"key":"460_CR40","doi-asserted-by":"crossref","first-page":"891748","DOI":"10.1155\/2013\/891748","volume":"2013","author":"KS Bhullar","year":"2013","unstructured":"Bhullar, K. S. & Rupasinghe, H. P. Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxid. Med. Cell Longev. 2013, 891748 (2013).","journal-title":"Oxid. Med. Cell Longev."},{"key":"460_CR41","volume":"8","author":"J Ryu","year":"2013","unstructured":"Ryu, J. et al. Phloroglucinol attenuates motor functional deficits in an animal model of Parkinson\u2019s disease by enhancing Nrf2 activity. PLoS ONE 8, e71178 (2013).","journal-title":"PLoS ONE"},{"key":"460_CR42","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/jcmm.12857","volume":"20","author":"D Cia","year":"2016","unstructured":"Cia, D. et al. Phloroglucinol protects retinal pigment epithelium and photoreceptor against all-trans-retinal-induced toxicity and inhibits A2E formation. J. Cell Mol. Med. 20, 1651\u20131663 (2016).","journal-title":"J. Cell Mol. Med."},{"key":"460_CR43","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","volume":"101","author":"PK Mukherjee","year":"2004","unstructured":"Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N. & Bazan, N. G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl Acad. Sci. USA 101, 8491\u20138496 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"460_CR44","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1167\/iovs.11-8569","volume":"53","author":"B Dornstauder","year":"2012","unstructured":"Dornstauder, B. et al. Dietary docosahexaenoic acid supplementation prevents age-related functional losses and A2E accumulation in the retina. Invest. Ophthalmol. Vis. Sci. 53, 2256\u20132265 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"460_CR45","volume":"6","author":"DS Rice","year":"2015","unstructured":"Rice, D. S. et al. Adiponectin receptor 1 conserves docosahexaenoic acid and promotes photoreceptor cell survival. Nat. Commun. 6, 6228 (2015).","journal-title":"Nat. Commun."},{"key":"460_CR46","doi-asserted-by":"crossref","first-page":"12054","DOI":"10.1074\/jbc.M117.790568","volume":"292","author":"H Shindou","year":"2017","unstructured":"Shindou, H. et al. Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells. J. Biol. Chem. 292, 12054\u201312064 (2017).","journal-title":"J. Biol. Chem."},{"key":"460_CR47","doi-asserted-by":"crossref","first-page":"15173","DOI":"10.1074\/jbc.M900322200","volume":"284","author":"A Maeda","year":"2009","unstructured":"Maeda, A. et al. Involvement of all-trans-retinal in acute light-induced retinopathy of mice. J. Biol. Chem. 284, 15173\u201315183 (2009).","journal-title":"J. Biol. Chem."},{"key":"460_CR48","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/mol.106.026823","volume":"70","author":"A Maeda","year":"2006","unstructured":"Maeda, A. et al. Effects of potent inhibitors of the retinoid cycle on visual function and photoreceptor protection from light damage in mice. Mol. Pharmacol. 70, 1220\u20131229 (2006).","journal-title":"Mol. Pharmacol."},{"key":"460_CR49","first-page":"171","volume":"23","author":"S Qi","year":"2017","unstructured":"Qi, S., Wang, C., Song, D., Song, Y. & Dunaief, J. L. Intraperitoneal injection of (-)-Epigallocatechin-3-gallate protects against light-induced photoreceptor degeneration in the mouse retina. Mol. Vis. 23, 171\u2013178 (2017).","journal-title":"Mol. Vis."},{"key":"460_CR50","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.bbadis.2018.04.014","volume":"1864","author":"Y Shin","year":"2018","unstructured":"Shin, Y. et al. A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 2420\u20132429 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"460_CR51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.freeradbiomed.2014.01.017","volume":"69","author":"G Aldini","year":"2014","unstructured":"Aldini, G., Carini, M., Yeum, K. J. & Vistoli, G. Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: toward the discovery of a novel class of bioactive compounds. Free Radic. Biol. Med. 69, 145\u2013156 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"460_CR52","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/pr.111.005538","volume":"64","author":"V Koppaka","year":"2012","unstructured":"Koppaka, V. et al. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol. Rev. 64, 520\u2013539 (2012).","journal-title":"Pharmacol. Rev."},{"key":"460_CR53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/14656566.2018.1448060","volume":"19","author":"RM Hussain","year":"2018","unstructured":"Hussain, R. M., Gregori, N. Z., Ciulla, T. A. & Lam, B. L. Pharmacotherapy of retinal disease with visual cycle modulators. Expert Opin. Pharmacother. 19, 471\u2013481 (2018).","journal-title":"Expert Opin. Pharmacother."},{"key":"460_CR54","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1074\/jbc.M110.178657","volume":"286","author":"L Ma","year":"2011","unstructured":"Ma, L., Kaufman, Y., Zhang, J. & Washington, I. C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease. J. Biol. Chem. 286, 7966\u20137974 (2011).","journal-title":"J. Biol. Chem."},{"key":"460_CR55","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.ophtha.2018.03.059","volume":"125","author":"PJ Rosenfeld","year":"2018","unstructured":"Rosenfeld, P. J. et al. Emixustat hydrochloride for geographic atrophy secondary to age-related macular degeneration: a randomized clinical trial. Ophthalmology 125, 1556\u20131567 (2018).","journal-title":"Ophthalmology"},{"key":"460_CR56","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00417-017-3619-8","volume":"255","author":"LJ Lu","year":"2017","unstructured":"Lu, L. J., Liu, J. & Adelman, R. A. Novel therapeutics for Stargardt disease. Graefes Arch. Clin. Exp. Ophthalmol. 255, 1057\u20131062 (2017).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"460_CR57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/14712598.2018.1513486","volume":"18","author":"RM Hussain","year":"2018","unstructured":"Hussain, R. M. et al. Stargardt macular dystrophy and evolving therapies. Expert Opin. Biol. Ther. 18, 1049\u20131059 (2018).","journal-title":"Expert Opin. Biol. Ther."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-020-0460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-020-0460-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-020-0460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:12:11Z","timestamp":1684617131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-0460-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1038\/s12276-020-0460-7","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"18 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Brabet, P., Cia, D., Guillou, L., Hamel, C., Vigor, C., Durand, T., Crauste, C., Vercauteren, J. New lipophenol compounds and uses thereof, WO2015162265A1 (2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patent"}}]}}